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ABSTRACT
Amblyopia is an early functional imbalance between each eye and the brain 
that may result in visual cortex inhibition. Current conservative treatments 
involve altering the input from the ‘good eye’, for example, using patching or 
biochemical penalization. Direct brain stimulation to the amblyopic cortex 
might improve the condition. This paper aimed to systematically review the 
published scientific literature regarding the use of transcranial magnetic 
stimulation (TMS) as a potential method for treatment in the amblyopic visual 
cortex. This study was a systematic review of the published scientific literature 
related to the TMS for the treatment of amblyopia that was performed using 
“TMS, amblyopia” as keywords. However, only three research papers were 
found and included in the literature review. A study showed that repetitive 
TMS of the visual cortex can temporarily improve contrast sensitivity in the 
amblyopic visual cortex. Another study used continuous theta burst stimulation 
(cTBS) delivered to the visual cortex while patients viewed a high contrast 
stimulus with their non-amblyopic eye. It was found that daily theta burst 
TMS stimulation improved amblyopic eye contrast sensitivity in five adult 
volunteers. The TMS also increased median visual acuity in the patient with 
amblyopia after stimulation with no significant changes in the placebo group.
Protocol employing repetitive administration of TMS might result in beneficial 
effects in amblyopia treatment. TMS works in brain dynamics and experience-
dependent plasticity, all of which could be important in investigating and 
treating amblyopia.
ABSTRAK
Ambliopia adalah ketidakseimbangan fungsi antara kedua mata dengan otak 
yang dapat menyebabkan hambatan korteks visual. Terapi konservatif saat 
ini melibatkan perubahan input dari ‘mata yang baik’ dengan menggunakan 
patching atau obat-obatan. Stimulasi otak langsung ke korteks ambliopik 
dapat mengatasi kondisi hambatan pada korteks visual tersebut. Makalah 
ini bertujuan untuk meninjau secara sistematis mengenai penggunaan 
stimulasi magnetik transkranial (Transcranial Magnetic Stimulation/TMS) 
sebagai metode potensial untuk pengobatan di korteks visual ambliopik. 
Tinjauan sistematis literatur ilmiah ini adalah mengenai penggunaan TMS 
untuk pengobatan ambliopia dengan menggunakan “TMS, amblyopia” sebagai 
kata kunci. Hanya tiga hasil penelitian yang ditemukan dan dapat digunakan 
dalam tinjauan literatur. Sebuah penelitian menunjukkan bahwa TMS pada 
korteks visual berulang dapat memperbaiki sensitivitas kontras sementara 
pada korteks visual ambliopik. Studi lain menggunakan stimulasi theta burst 
yang diberikan pada korteks visual saat pasien melihat stimulus kontras 
tinggi dengan mata non-ambliopik. Ditemukan bahwa stimulasi theta burst 
TMS secara teratur meningkatkan sensitivitas kontras mata ambliopik pada 
lima relawan dewasa. TMS juga meningkatkan median ketajaman visual pada 
pasien dengan ambliopia setelah stimulasi tanpa perubahan signifikan pada 
kelompok plasebo. Protokol pemberian TMS berulang bermanfaat dalam 
pengobatan ambliopia. TMS bekerja dalam dinamika otak dan experience-
dependent plasticity.
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INTRODUCTION
Early visual deprivation, for instance, 
as a result of cataracts or due to refractive 
error, causes a reduction in the early 
sensory input that plays an important role 
in tuning the visual cortex.1 Amblyopia 
is the most common cause of monocular 
visual loss in children and young adults, 
occurring at a rate between 1 and 3.5% in 
developed countries.2 This condition is the 
result of reduced processing of the neural 
signals related to visual information 
from the amblyopic eye during visual 
development and is clinically defined as a 
two-line difference (in Snellen’s chart) of 
best-corrected visual acuity between the 
eyes.3 Several problems can commonly 
lead to amblyopia, either alone (e.g. a need 
for glasses as a consequence of refractive 
error, strabismus) or in combination.2
Conservative approaches, such 
as refractive correction or optical 
penalization using either pharmacological 
or physical methods, are often used in 
current treatments of amblyopia. The 
latter may use an eye patch or surgical 
interventions; for example, cataract 
extraction needs to be performed. In 
terms of examining the effectiveness of 
physical interventions, a study of patients 
with both moderate and severe bilateral 
amblyopia found excellent improvement 
in visual acuity with the use of glasses 
alone.4 Another study investigating 
moderate amblyopia reported that, when 
an eye patch was used as treatment, a 
greater number of hours of patching 
did not produce either a clinically or 
statistically significant effect when used 
for six months.5 It was reported, however, 
a faster rate of initial rate of improvement 
in a group patched for 6 hours daily 
compared with a group patched for 
two hours. When the use of atropine 
on weekends in severe amblyopia was 
assessed, a similar potential for effective 
improvement in visual acuity was 
observed.6,7 Patients with full glasses 
correction and weekend atropine 
administration showed an average of 
4.5 lines of improvement after 18 weeks. 
A study showed that visual acuity was 
significantly better in those receiving 
citicoline and patching than in the group 
receiving only patching.8
Transcranial magnetic stimulation 
(TMS) is a tool that can make it possible 
to evaluate the need for the role of the 
brain region in cognitive function. 
This primarily means that it can 
provide an alternative to lesion-based 
investigations, which means that more 
tasks and functions can be investigated 
and have good spatial characteristics 
and excellent resolution in the temporal 
domain.9,10 Since its development as a 
viable experimental tool, researchers 
have used TMS to investigate numerous 
functions, including (but not limited 
to) investigating parietal neglect, 
studies of the perception of visual 
motion, perceptual priming, the role 
of synchronized cortical discharge, 
conscious visual awareness, visual 
search and study of interactions between 
cortical areas.11-20
While   treatment  regarding 
refractive correction is only effective 
in treating  the   refractive  cause of 
amblyopia, suppression using  patching 
and atropine are not beneficial in terms 
of restoration of binocular function. 
If it is reasonable, one of the ideal 
objectives when treating amblyopia 
is an improvement of vision by 
eliminating the inhibitory signal from 
the normal eye and allowing normal 
development related to the amblyopic 
eye to occur. Therefore, a combination 
of stimulation of the suppressed neural 
system in combination with reduction 
of the suppression from the other eye 
may be necessary as first steps in any 
binocular therapy. This paper aimed 
to systematically review the published 
scientific literature regarding the use of 
TMS as a potential method for treatment 
in the amblyopic visual cortex before 
conducting TMS in amblyopia patients.
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MATERIALS AND METHODS
Literature research
A systematic literature search was 
undertaken during the period of October 
2019. Search strategies were performed 
to identify literature pertaining to 
amblyopia, amblyopia treatment, 
children, and TMS terms. No date or 
language restrictions were applied. 
A total of 236 articles were identified 
through the database searches. Letters, 
reviews, and editorials describing other 
studies reporting TMS application in 
amblyopia were excluded. Only three 
articles were eligible for analysis after 
identification through the database 
searches.
Data extraction and synthesis
The papers examined were in terms 
of instruments, patient selection, and 
TMS protocol.
FIGURE 1. PRISMA flow diagram of study identification
RESULTS
The use of TMS in amblyopia 
treatment is relatively new and has 
not been developed before. There have 
been only a few studies investigating 
the effects of TMS in treating amblyopia. 
One study showed that repetitive TMS 
of the visual cortex can temporarily 
improve contrast sensitivity in the 
amblyopic visual cortex.21 In this 
study, 7 of 9 patients responded to 1 Hz 
TMS stimulation at one or both post-
TMS time points investigated. When 
10 Hz stimulation was used, all six 
participants tested showed improved 
contrast sensitivity at both time points. 
Importantly, both participants who did 
not respond to 1 Hz stimulation did 
show a response to 10 Hz stimulation.21 
Another study used continuous theta-
burst stimulation (cTBS) delivered to 
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the visual cortex while patients viewed 
a high contrast stimulus with their non-
amblyopic eye. It was found that daily 
theta-burst TMS stimulation improved 
amblyopic eye contrast sensitivity in five 
adult volunteers.22 cTBS was effective 
in improving amblyopic eye contrast 
sensitivity for high spatial frequencies, 
with an improvement across sessions. 
Asymptotic levels of performance 
were attained after just two daily 
sessions of stimulation. Notably, such 
improvements were stable up to 78 days 
after stimulation.22
A current study included eight 
participants (six women and two men) 
with amblyopia with a median visual 
acuity after stimulation of 0.18 (0.05–
0.34) (before stimulation: 0.28; range: 
0.14–0.49) and no significant changes in 
visual acuity for the placebo group.23
TABLE 1. Summary of the previous research
Study Protocol Design Stimulation area
Control 
area Stimulus Parameter Effect
Thompson et al.21 1 Hz repetitive 












% contrast 2.5% contrast 
increment
Clavagnier et al.22 Continuous 
theta-burst TMS
Experimental 








Log-contrast 0.5 log-contrast 
increment


















Note: TMS: transcranial magnetic stimulation; MRI: magnetic resonance imaging
DISCUSSION
There were very few studies 
that involved the application of TMS 
in amblyopia patients; therefore, it 
might provide a wide opportunity for 
researchers in this field to develop a 
more standard TMS protocol and safety 
procedure to be applied to amblyopia 
patients. From the results of this study, 
the application of TMS to the amblyopic 
visual cortex has been found to improve 
contrast sensitivity,21 albeit temporarily. 
Either repeated TMS or theta burst 
stimulation has been shown to modulate 
abnormal interhemispheric patterns of 
suppression inhibition within the human 
cortex, which leads to the suggestion 
that these techniques may be useful 
in reducing pathological suppression. 
Delivery of repetitive TMS effectively 
causes externally induced changes in 
neuronal spiking, meaning that cortical 
activity can be altered in a manner that 
is both spatially and temporally precise. 
Under normal conditions, TMS could 
excite a functional inhibitory circuitry. 
An example of this is the circuit between 
the prefrontal cortex and the superior 
colliculus involved in the control of eye 
movements.24
Brain plasticity determines the 
effectiveness of TMS in exciting the 
suppressed brain area in amblyopic 
patients. It is assumed that the amblyopic 
eye is capable of functioning well since 
a surprising level of plasticity after age 
6 has been shown in individuals with 
amblyopia1. The effects of excitatory 
stimulation also tend to be more 
pronounced for neurons with a recent 
history of suppression, and it also seems 
that the effects of inhibitory stimulation 
may be more pronounced for recently 
activated neurons.25-27  It has been shown 
that TMS delivered to the visual cortex 
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can result in modulation of a range of 
measures, including contrast sensitivity, 
motion perception, visual evoked 
potentials and phosphene thresholds, 
the latter being the strength of a single 
pulse of TMS delivered to the occipital 
lobe needed to induce the percept of a 
phosphene and often used as a measure 
of visual cortex excitability.9 TMS has 
also been suggested to be potentially 
beneficial in terms of resulting in 
therapeutic effects in patients, with 
promotion of exogenous plasticity that 
may have a “potentiating effect” when it 
occurs in combination with endogenous 
mechanisms.28
Importantly, there is currently no 
evidence of undesirable short-term 
or long-term effects related to the use 
of TMS, and it is commonly described 
as a “relatively painless method” for 
noninvasive brain stimulation.11,29 
However, this certainly does not mean 
safety should not be a major factor that is 
considered when using TMS in humans, 
and even more so when considering use 
in children. Frye et al.29  reviewed studies 
specifically in terms of considering the 
diagnostic and therapeutic use of TMS 
in child populations. They looked at 
84 studies involving the use of TMS in 
children, with a total of more than 800 
normal children and 300 neurologically 
abnormal children.29  Fifteen  of  the 
studies evaluated mentioned no 
occurrences of any side effects, one 
mentioned that there was an adverse 
effect,29 and another study mentioned 
that stimulation had resulted in a 
transient dullness on the subject’s left 
upper limb.30,31 One possible source 
of concern relates to the smaller size 
(circumference) of children’s heads 
compared to adults. However, despite 
this smaller head circumference, the 
actual brain volume does not vary much 
from six years of age.32 In addition, open 
fontanels in young children younger 
than 18 months indicate the need for 
special care  related to coil  placement 
to prevent mechanical injury. The 
potential effects of an open fontanel on 
the distribution-induced electrical field 
should also be considered.33
An  additional   issue  for 
consideration, and of significant 
relevance to the quality of the data in 
a study, is that TMS delivery can cause 
significant sensory sensations that might 
result in nonspecific interference with 
task performance. These include a loud 
clicking sound when the stimulator 
is discharged, as well as potential for 
stimulation of both cranial nerves 
and direct activation of facial and 
neck muscles.29 Despite these issues, 
the previous study found no evidence 
of hearing loss in humans due to the 
noise associated with TMS, with the 
risk of hearing loss from the sounds 
that result from magnetic stimulation 
that seems to be small.34 These sounds 
can be minimized, with benefits for 
both data collection and, importantly, 
minimization of any potential health 
effects, by use of hearing protection 
such as earplugs or earmuffs when TMS 
is delivered. However, there are no 
data on the risks of hearing damage in 
children less than two years of age, and 
guidelines suggest special care must be 
taken to protect hearing, such as the use 
of specialized hearing protection when 
applying TMS to children.33
However, it is currently not possible 
to identify the exact mechanisms that 
result in rTMS-based improvement in 
visual functions. It has been suggested 
that TMS may promote equality in 
neural excitability between the two eyes. 
This may act to return a neural system 
to equilibrium in amblyopics.21 Future 
studies have the potential to assess this 
more specifically.
CONCLUSION
In conclusion, TMS has the potential 
to improve visual acuity and contrast 
sensitivity in amblyopia patients. 
362
J Med Sci, Volume 52, Number 4, 2020, October: 357-364
However, there is a lack of standardized 
protocols and outcome parameters. 
TMS is generally safe for use in human 
subjects (when employed in a suitable 
manner and following appropriate 
guidelines) and has been widely 
employed in numerous experiments 
to test hypotheses related to a range of 
cognitive processes as well as to offer 
insight into both local and global brain 
network organization, brain dynamics 
and experience-dependent plasticity, 
all of which could be important in 
investigating and treating amblyopia. 
Specifically, data collected so far seem 
to suggest that a protocol employing 
repetitive administration of TMS may 
result in beneficial effects that persist 
beyond the period of stimulation.
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